Clin2
NCT07161180Likely a fitRecruiting

Study of PBK_M2301 in Healthy Adults

Healthy Volunteers

This trial tests how a new medicine, PBK_M2301, moves through the body in healthy adults. It aims to find out how the drug is absorbed and eliminated to guide future studies.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
32 people
Ages
19 years to 65 years
Study type
Interventional

Who can take part

  • You are between 19 and 64 years old
  • Your weight is within a healthy range (BMI 18–30), with men weighing at least 110 pounds and women at least 99 pounds
  • You are generally healthy with no major chronic conditions or recent drug use that could affect the results
  • You agree to use effective contraception (non-hormonal) and not donate sperm or eggs from the first dose until one week after the last dose

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07311811Not yet recruiting· Phase 1
Study of two drugs in healthy volunteers

This trial tests how two experimental drugs, IN-M00007 and IN-R00007, move through the body and how safe they are. It is for healthy adults to gather basic information before testing in patients.

Seoul
NCT07522970Recruiting· Phase 1
Safety and Tolerability Study of LG-0317 in Healthy Adults

This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.

Shanghai, Shanghai Municipality
NCT07527221Recruiting· Phase 1
Safety study of ZE74-0282 in healthy adults

This is an early-stage safety study testing a new experimental drug called ZE74-0282 in healthy volunteers. Researchers want to learn how safe the drug is and how well people tolerate it before testing it in patients with a disease.

Randwick, New South Wales
NCT06635226Recruiting· Phase 1
Safety study of ID110521156 in healthy adults

This study tests a new investigational drug called ID110521156 in healthy adults. The goal is to see if the drug is safe and how the body processes it. It may be for people who are overweight or obese.

Seoul
NCT07254481Recruiting· Phase 1
Safety study of VB19055 in healthy volunteers

This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.

Hangzhou
NCT06899815Recruiting· Phase 1
Early safety study of F230 tablets in healthy volunteers

This trial tests a new medicine, F230, in healthy people for the first time. The goal is to check how safe it is and how the body handles it. You might consider this if you are a healthy adult looking to help advance medical research.

Hubei, Wuhan

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.